View Item 

Show simple item record

Diffusion Weighted MRI in NCTN Clinical Trials Meeting Series: Summary and Recommendations
dc.contributor.authorChenevert, Thomas
dc.coverage.spatialVirtual meeting series on Diffusion-Weighted MRI in NCTN Clinical Trials
dc.date.accessioned2022-12-15T20:02:37Z
dc.date.available2022-12-15T20:02:37Z
dc.date.issued2022-12-13
dc.identifier.urihttps://hdl.handle.net/2027.42/175272
dc.description.abstractBrief summary on technical challenges and recommendations for next steps to incorporate DWI in Phase 2-3 clinical trials
dc.description.sponsorshipNIH National Cancer Institute Clinical Imaging Steering Committee (CISC) i
dc.subjectApparent Diffusion Coefficient
dc.subjectDiffusion Weighted Imaging
dc.subjectMRI
dc.subjectNCTN Clinical Trials
dc.subjectQuantitative Imaging
dc.titleDiffusion Weighted MRI in NCTN Clinical Trials Meeting Series: Summary and Recommendations
dc.typePresentation
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/175272/2/20221213_DWI Summary Recommendations_Chenevert_DWI_Technical_final.pdf
dc.identifier.doihttps://dx.doi.org/10.7302/6653
dc.date.updated2022-12-15T20:02:36Z
dc.identifier.orcid0000-0003-1476-4274
dc.identifier.name-orcidChenevert, Thomas; 0000-0003-1476-4274
dc.working.doi10.7302/6653en
dc.owningcollnameRadiology, Department of


Files in this item

Name:
20221213_DWI Summary Recommend ...
Size:
142.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.